Phase 2 N=158 A Study of Ramucirumab or Icrucumab in Colorectal Cancer
Colon Cancer · Rectal Cancer
Primary: Progression-Free Survival (PFS) — 18.4; 21.4; 15.9 Weeks
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=251 Web-based Smoking Cessation Program for Tribal College Students
Smoking Cessation
Primary: Number of Participants With 7-day Point Prevalence Abstinence — 9; 9 Participants
N/A N=24 Nanopulse Efficacy Study for the Treatment of Common Warts
Common Warts
Primary: Clinical Clearance of Warts — 13; 4; 2 # of warts
Phase 3 N=692 A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
Non-Hodgkin's Lymphoma
Primary: Maintenance II: Progression-free Survival (PFS) Using 1999 International Working Group (Cheson) Response Criteria for Lymphoma or by the Recommendations for…
N/A N=49 Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
Schizophrenia · Schizoaffective Disorder · Bipolar Disorder
Primary: HDL Ratio — 39.7; 38.4; 43.5; 42.3 unit of Measure ''g/dL''
Phase 4 N=23 Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis
Allergic Conjunctivitis
Primary: Change From Baseline in Ocular Itching at 14 Days — 2.17; 1.82 units on a scale
N/A N=101 Peace-Building Interventions for Israeli and Palestinian Youth
Healthy
Primary: Behavioral Assessment of Dialogue — 3.07; 3.21; 2.26; 2.23 units on a scale
N/A N=124 Comparison of Modified Circular and Natural Tooth Brushing Methods in Effectiveness of Dental Plaque Removal
Healthy
Primary: Baseline Plaque Level — 2.25; 2.28 plaque index — p=>0.05
Phase 3 N=120 Safety and Efficacy of Alteplase When Administered in Chinese Patients With Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4.5 Hours After Stroke Onset
Stroke
Primary: The Percentage of Patients With Modified Rankin Scale (mRS 0-1) (Favourable Outcome) Response at Day 90 After Stroke Onset by Face-to-face Interview With Patient — 42.5…
N/A N=100 The Effects of Swimming on Elderly Women With Stage-2 Hypertension
Menopause · Hypertension
Primary: Arterial Stiffness — 7.8; 10.0 m/s
Phase 4 N=108 Combined Bleaching Technique: Efficacy and Tooth Sensitivity
Tooth Bleaching · Tooth Sensitivity
Primary: Tooth Sensitivity (TS) — 1; 1; 1; 0 score on a scale
Phase 4 N=1,053 Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis
Osteoporosis
Primary: The Change of Bone Mineral Density (BMD) Value — 0.77; 0.77; 0.81; 0.80 g/cm^2
Phase 1 N=50 Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis: A Pilot Feasibility Study
Shock, Septic
Primary: Compliance With Study Fluid Administration in the Assigned Study Arm — 0; 100 Proportion of total crystalloids adminis
N/A N=50 Interest in Electronic Applications for Patients With Glaucoma
Glaucoma
Primary: Patients Owning Smartphone/Tablet Technology — 34 Participants
Phase 1 N=120 Safety, Tolerability and Pharmacokinetics and Effect on Inflammation of Oral BI 1026706 in Patients With COPD
Pulmonary Disease, Chronic Obstructive
Primary: Safety and Tolerability of BI 1026706, as Assessed by Frequency (in Percent) of Patients With Treatment Emergent Adverse Events (TEAEs) Over the Treatment Period…